Effect of Alfacalcidol on Inflammatory markers and T Cell Subsets in Elderly with Frailty Syndrome: a Double Blind Randomized Controlled Trial
Background: Alphacalcidol, a vitamin D analog, shows immune regulatory potency as it works on the macrophage and T cell to control inflammation and T cell dysregulation in elderly. None has been known about its effect on elderly with various states of frailty syndrome, which have different level of...
Main Authors: | Aulia Rizka, Siti Setiati, Kuntjoro Harimurti, M Sadikin, Indra G Mansur |
---|---|
Format: | Article |
Language: | English |
Published: |
Interna Publishing
2018-10-01
|
Series: | Acta Medica Indonesiana |
Subjects: | |
Online Access: | http://actamedindones.org/index.php/ijim/article/view/622 |
Similar Items
-
Treatment of osteoporosis with eldecalcitol, a new vitamin D analog: a comprehensive review and meta-analysis of randomized clinical trials
by: Xu Z, et al.
Published: (2016-01-01) -
Pulse versus daily oral Alfacalcidol treatment of secondary hyperparathyroidism in hemodialysis patients: a randomized controlled trial
by: Sawalmeh O, et al.
Published: (2018-01-01) -
Impact of Frailty on the First 30 Days of Major Cardiac Events in Elderly Patients with Coronary Artery Disease Undergoing Elective Percutaneous Coronary Intervention
by: Rachmat Hamonangan, et al.
Published: (2016-09-01) -
Osteopenia prevalence in ankylosing spondylitis and its correction with alphacalcidol
by: B. V. Zavodovsky, et al.
Published: (2005-02-01) -
The Impact of Frailty on 30-day Post-Elective Surgery Complications in Elderly Patients: a Prospective Cohort Study
by: Noto Dwimartutie, et al.
Published: (2020-12-01)